🎯 Other
Will the FDA approve retatrutide?
Will the FDA approve retatrutide? — Before Jan 1, 2029
Live
Resolves Jan 1, 2029KalshiVolume-weighted avg
92%
No
8%
No (8%)Yes (92%)
Probability History
Loading...
Market snapshot
Status
Open
Category
Other
Vol 24h
—
Liquidity
$82
Market intelligence
Kalshi currently prices this at 92%.
About this market
If the FDA approves retatrutide (LY3437943) for marketing before Jan 1, 2029, then the market resolves to Yes.
Resolution
Jan 1, 2029
Market is open
Market stats
24h volume—
Liquidity$82
CategoryOther
StatusOpen